Abstract
In the present study, we investigated the inhibitory natural killer cell receptor (NKR) expression of CD94/NKG2A on PBMC after allogeneic bone marrow transplantation (BMT). The proportion of CD94 expression on PBMC was higher in patients without chronic graft-versus-host disease (cGVHD) and also in cGVHD patients with good response to conventional immunosuppressive therapy than in cGVHD patients with poor response. Also, the proportions of CD94+/CD3+ cells and CD94+/CD8+ cells were higher in cGVHD patients showing good response. In addition, the proportion of NKG2A-expressing cells was higher in patients without cGVHD than in patients with cGVHD. Therefore, chronic allostimulation after allo-BMT may augment the proportion of CD94/NKG2A-positive cells, and these cells may play some role in the regulation of alloresponse in some patients.
Copyright 2001 S. Karger AG, Basel.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antigens, CD / metabolism*
-
Bone Marrow Transplantation / immunology
-
CD3 Complex
-
CD8-Positive T-Lymphocytes
-
Case-Control Studies
-
Graft vs Host Disease / blood
-
Graft vs Host Disease / immunology
-
Hematologic Neoplasms / blood
-
Hematologic Neoplasms / complications
-
Hematologic Neoplasms / therapy
-
Humans
-
Killer Cells, Natural / cytology
-
Killer Cells, Natural / metabolism
-
Lectins, C-Type*
-
Leukocytes, Mononuclear / immunology*
-
Membrane Glycoproteins / metabolism*
-
NK Cell Lectin-Like Receptor Subfamily C
-
NK Cell Lectin-Like Receptor Subfamily D
-
Receptors, Immunologic / metabolism
-
Receptors, Natural Killer Cell
-
T-Lymphocytes
-
Transplantation, Homologous / immunology*
-
Treatment Outcome
Substances
-
Antigens, CD
-
CD3 Complex
-
KLRC1 protein, human
-
KLRD1 protein, human
-
Lectins, C-Type
-
Membrane Glycoproteins
-
NK Cell Lectin-Like Receptor Subfamily C
-
NK Cell Lectin-Like Receptor Subfamily D
-
Receptors, Immunologic
-
Receptors, Natural Killer Cell